June 24, 2024 11:05 AM EDT
Pharma

UK taps Pfiz­er over home­town GSK to sup­ply RSV vac­cine dos­es

Max Bayer

Pharma Reporter

The UK gov­ern­ment has se­lect­ed Pfiz­er to sup­ply mil­lions of res­pi­ra­to­ry syn­cy­tial virus (RSV) vac­cine dos­es, snub­bing lo­cal phar­ma com­pa­ny GSK and its com­pet­ing prod­uct …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­Marin re­struc­tures fol­low­ing staff shake­up, slow Roc­ta­vian sales

Lil­ly inks obe­si­ty deal with seed-stage RNA start­up as its ge­net­ic med­i­cines ef­fort en­ters the spot­light

Court or­ders J&J to pay $1B fol­low­ing buy­out of sur­gi­cal ro­bot­ics com­pa­ny

Cell ther­a­py start­up Ar­se­nal­Bio rais­es $325M as it runs ear­ly sol­id tu­mor tri­als

High­er dose of Spin­raza helped spinal mus­cu­lar at­ro­phy pa­tients, Bio­gen says

sponsored

How to se­cure full en­roll­ment and a 30x ROI: A con­ver­sa­tion with the CEO of the bou­tique en­roll­ment agency do­ing just ...

A service from the Financial Times